Compare LE & ORGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | LE | ORGO |
|---|---|---|
| Founded | 1963 | 1985 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Clothing/Shoe/Accessory Stores | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 334.7M | 348.6M |
| IPO Year | 1994 | 2016 |
| Metric | LE | ORGO |
|---|---|---|
| Price | $12.00 | $2.55 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 2 |
| Target Price | ★ $32.50 | $8.50 |
| AVG Volume (30 Days) | 579.2K | ★ 1.5M |
| Earning Date | 06-04-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 1600.00 |
| EPS | ★ 0.18 | 0.15 |
| Revenue | ★ $1,162,769,000.00 | $564,169,000.00 |
| Revenue This Year | $5.53 | N/A |
| Revenue Next Year | $2.48 | $26.27 |
| P/E Ratio | $64.17 | ★ $17.33 |
| Revenue Growth | 0.72 | ★ 17.04 |
| 52 Week Low | $7.65 | $2.21 |
| 52 Week High | $20.04 | $7.08 |
| Indicator | LE | ORGO |
|---|---|---|
| Relative Strength Index (RSI) | 45.22 | 48.21 |
| Support Level | $11.16 | $2.26 |
| Resistance Level | $13.83 | $2.57 |
| Average True Range (ATR) | 0.76 | 0.17 |
| MACD | 0.19 | 0.08 |
| Stochastic Oscillator | 46.01 | 72.54 |
Lands' End Inc is a United States-based digital retailer of solution-based apparel, swimwear, outerwear, accessories, footwear, home products, and uniforms. It offers products online at the website (www.landsend.com), through third-party distribution channels, its own company-operated stores, and third-party license agreements. Lands' End also offers products to businesses and schools, for their employees and students, through the Outfitters distribution channel. The company's operating segments consist of: U.S. eCommerce, Europe eCommerce, Outfitters, Third Party, Licensing, and Retail. The majority of its revenue is generated from the U.S. eCommerce segment. Geographically, Lands' End derives maximum revenue from the United States, and the rest from Europe and other markets.
Organogenesis Holdings Inc is a regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the advanced wound care, surgical, and sports medicine markets. The company's portfolio of regenerative medicine products in the advanced wound care category includes Apligraf, Dermagraft, PuraPly AM, CYGNUS Dual, etc., and the sports medicine products include NuShield as a surgical barrier and PuraForce as a reinforcement matrix in targeted soft tissue repairs; and Affinity, Novachor, PuraPly MZ, PuraPly AM, and PuraPly SX for management of open wounds in the surgical setting. The company operates in a single segment, that is, regenerative medicine.